Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
M3V.DE Stock Summary
In the News
M3V.DE Financial details
Company Rating
Strong Buy
Market Cap
45.5M
Income
11.59M
Revenue
33.04M
Book val./share
9.79
Cash/share
-4.66
Dividend
-
Dividend %
-
Employees
101
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
5.89
Forward P/E
-
PEG
1.21
P/S
2.44
P/B
2.57
P/C
-5.36
P/FCF
9.71
Quick Ratio
0.96
Current Ratio
1.5
Debt / Equity
-0.09
LT Debt / Equity
-
-
-
EPS (TTM)
6.37
EPS next Y
-
EPS next Q
-
EPS this Y
-36.92%
EPS next Y
-
EPS next 5Y
-77.08%
EPS last 5Y
-9.43%
Revenue last 5Y
-0.82%
Revenue Q/Q
4.69%
EPS Q/Q
70%
-
-
-
-
SMA20
-2.71%
SMA50
-1.74%
SMA100
-6.13%
Inst Own
-
Inst Trans
-
ROA
25%
ROE
44%
ROC
0.37%
Gross Margin
96%
Oper. Margin
42%
Profit Margin
42%
Payout
58%
Shs Outstand
1.82M
Shs Float
1.82M
-
-
-
-
Target Price
-
52W Range
23.0-35.8
52W High
-28.57%
52W Low
+8.7%
RSI
51.52
Rel Volume
-
Avg Volume
109
Volume
Perf Week
3.31%
Perf Month
-0.79%
Perf Quarter
-10.71%
Perf Half Y
-11.35%
-
-
-
-
Beta
0.075
-
-
Volatility
0.23%, 0.4%
Prev Close
0%
Price
25
Change
0.81%
M3V.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.93 | 9.41 | 8.91 | 10.31 | 9.53 | |
Net income per share | 4.43 | 3.13 | 2.5 | 4.28 | 2.7 | |
Operating cash flow per share | 3.6 | 1.59 | 5.02 | 2.67 | 3.22 | |
Free cash flow per share | 3.48 | 1.53 | 4.99 | 2.6 | 3.17 | |
Cash per share | -7.49 | -6.74 | -4.73 | -3.79 | -4.66 | |
Book value per share | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 | |
Tangible book value per share | 9.78 | 9.79 | 9.79 | 9.79 | 9.79 | |
Share holders equity per share | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 | |
Interest debt per share | -1.02 | -0.85 | -0.96 | -0.83 | -0.89 | |
Market cap | 54.24M | 57.88M | 59.33M | 62.24M | 51.69M | |
Enterprise value | 51.64M | 53.92M | 51.71M | 52.92M | 43.94M | |
P/E ratio | 6.72 | 10.15 | 13.05 | 7.99 | 10.51 | |
Price to sales ratio | 3 | 3.38 | 3.66 | 3.32 | 2.98 | |
POCF ratio | 8.29 | 20.03 | 6.5 | 12.81 | 8.83 | |
PFCF ratio | 8.55 | 20.76 | 6.53 | 13.18 | 8.95 | |
P/B Ratio | 3.04 | 3.25 | 3.33 | 3.49 | 2.9 | |
PTB ratio | 3.04 | 3.25 | 3.33 | 3.49 | 2.9 | |
EV to sales | 2.86 | 3.15 | 3.19 | 2.82 | 2.53 | |
Enterprise value over EBITDA | 6.13 | 9.03 | 9.62 | 6.64 | 8.5 | |
EV to operating cash flow | 7.89 | 18.66 | 5.66 | 10.9 | 7.51 | |
EV to free cash flow | 8.14 | 19.35 | 5.69 | 11.2 | 7.61 | |
Earnings yield | 0.15 | 0.1 | 0.08 | 0.13 | 0.1 | |
Free cash flow yield | 0.12 | 0.05 | 0.15 | 0.08 | 0.11 | |
Debt to equity | -0.1 | -0.09 | -0.1 | -0.09 | -0.09 | |
Debt to assets | -0.08 | -0.06 | -0.06 | -0.05 | -0.06 | |
Net debt to EBITDA | -0.31 | -0.66 | -1.42 | -1.17 | -1.5 | |
Current ratio | 2 | 1.48 | 1.63 | 1.5 | 1.66 | |
Interest coverage | 829.82 | 495.07 | 485.12 | 2.05K | 118.55 | |
Income quality | 0.81 | 0.51 | 2.01 | 0.62 | 1.19 | |
Dividend Yield | 0.03 | 0.03 | 0.1 | 0.07 | 0.15 | |
Payout ratio | 0.2 | 0.28 | 1.25 | 0.58 | 1.58 | |
Sales general and administrative to revenue | 0.03 | 0.04 | 0.05 | 0.02 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.03 | -0.04 | -0.01 | -0.03 | -0.01 | |
Capex to revenue | -0.01 | -0.01 | 0 | -0.01 | 0 | |
Capex to depreciation | -0.79 | -0.61 | -0.41 | -1.43 | -0.83 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 31.26 | 26.28 | 23.46 | 30.71 | 24.41 | |
ROIC | 0.51 | 0.35 | 0.32 | 0.48 | 0.31 | |
Return on tangible assets | 0.34 | 0.21 | 0.17 | 0.25 | 0.18 | |
Graham Net | -8.99 | -9.47 | -8.88 | -9.15 | -8.91 | |
Working capital | 3.56M | 3.58M | 4.22M | 4.83M | 4.52M | |
Tangible asset value | 17.81M | 17.82M | 17.83M | 17.83M | 17.83M | |
Net current asset value | 1.03M | 1.09M | 1.17M | 1.13M | 1.14M | |
Invested capital | -0.1 | -0.09 | -0.1 | -0.09 | -0.09 | |
Average receivables | 2.21M | 5.53M | 4.72M | 3.77M | 4.03M | |
Average payables | 173.28K | 51.66K | 166.25K | 216.16K | 134.65K | |
Average inventory | 47.19K | 71.36K | 74.27K | 116.82K | 57.25K | |
Days sales outstanding | 89.1 | 141.61 | 63 | 92.17 | 70.13 | |
Days payables outstanding | 8.44 | 54.06 | 200.32 | 94.15 | 62.91 | |
Days of inventory on hand | 75.38 | 28.17 | 83.72 | 65.24 | -15.53 | |
Receivables turnover | 4.1 | 2.58 | 5.79 | 3.96 | 5.2 | |
Payables turnover | 43.25 | 6.75 | 1.82 | 3.88 | 5.8 | |
Inventory turnover | 4.84 | 12.96 | 4.36 | 5.59 | -23.5 | |
ROE | 0.45 | 0.32 | 0.26 | 0.44 | 0.28 | |
Capex per share | -0.11 | -0.06 | -0.03 | -0.07 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q4
Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 5.61 | 4.66 | 4.87 | |
Net income per share | 0 | 0 | 2.4 | 1 | 1.7 | |
Operating cash flow per share | 0 | 0 | 0.05 | 0.05 | 0.05 | |
Free cash flow per share | 0 | 0 | 0.05 | 0.05 | 0.05 | |
Cash per share | 0 | 0 | -3.79 | -6.49 | -4.66 | |
Book value per share | 0 | 0 | 9.79 | 9.79 | 9.79 | |
Tangible book value per share | 0 | 0 | 9.79 | 9.79 | 9.79 | |
Share holders equity per share | 0 | 0 | 9.79 | 9.79 | 9.79 | |
Interest debt per share | 0 | 0 | -0.83 | -0.99 | -0.91 | |
Market cap | 0 | 0 | 62.24M | 65.16M | 51.69M | |
Enterprise value | -7.62M | -4.31M | 52.92M | 60.74M | 43.94M | |
P/E ratio | 0 | 0 | 3.56 | 8.91 | 4.18 | |
Price to sales ratio | 0 | 0 | 6.09 | 7.69 | 5.83 | |
POCF ratio | 0 | 0 | 719.18 | 685.55 | 534.89 | |
PFCF ratio | 0 | 0 | 719.18 | 685.55 | 534.89 | |
P/B Ratio | 0 | 0 | 3.49 | 3.66 | 2.9 | |
PTB ratio | 0 | 0 | 3.49 | 3.66 | 2.9 | |
EV to sales | 0 | 0 | 5.18 | 7.17 | 4.95 | |
Enterprise value over EBITDA | 0 | 0 | 15.76 | 25 | 20.61 | |
EV to operating cash flow | 0 | 0 | 611.49 | 639.09 | 454.75 | |
EV to free cash flow | 0 | 0 | 611.49 | 639.09 | 454.75 | |
Earnings yield | 0 | 0 | 0.07 | 0.03 | 0.06 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | -0.09 | -0.1 | -0.09 | |
Debt to assets | 0 | 0 | -0.05 | -0.07 | -0.06 | |
Net debt to EBITDA | 0 | 0 | -2.78 | -1.82 | -3.63 | |
Current ratio | 1.63 | 1.66 | 1.5 | 2.02 | 1.66 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0.02 | 0.05 | 0.03 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 23 | 14.88 | 19.34 | |
ROIC | 0 | 0 | 0.2 | 0.14 | 0.13 | |
Return on tangible assets | 0 | 0 | 0.14 | 0.08 | 0.11 | |
Graham Net | 0 | 0 | -9.15 | -8.89 | -8.91 | |
Working capital | 4.22M | 3.51M | 4.83M | 3.87M | 4.52M | |
Tangible asset value | 17.83M | 17.83M | 17.83M | 17.83M | 17.83M | |
Net current asset value | 1.17M | 1.17M | 1.13M | 1.12M | 1.14M | |
Invested capital | 0 | 0 | -0.09 | -0.1 | -0.09 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 41.74 | 29.69 | 33.81 | |
Days payables outstanding | 0 | 0 | 3.07 | 0.35 | 1.27 | |
Days of inventory on hand | 0 | 0 | 2.13 | 2.85 | -0.31 | |
Receivables turnover | 0 | 0 | 2.16 | 3.03 | 2.66 | |
Payables turnover | 0 | 0 | 29.34 | 255.81 | 70.89 | |
Inventory turnover | 0 | 0 | 42.34 | 31.56 | -287.09 | |
ROE | 0 | 0 | 0.25 | 0.1 | 0.17 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
M3V.DE Frequently Asked Questions
What is MeVis Medical Solutions AG stock symbol ?
MeVis Medical Solutions AG is a DE stock and trading under the symbol M3V.DE
What is MeVis Medical Solutions AG stock quote today ?
MeVis Medical Solutions AG stock price is $25 today.
Is MeVis Medical Solutions AG stock public?
Yes, MeVis Medical Solutions AG is a publicly traded company.